Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …

Lenvatinib, which is an oral multikinase inhibitor, showed non-inferiority to the sorafenib in
terms of overall survival (OS) and a higher objective response rate (ORR) and better …

Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

Simple Summary This is a systematic and meta-analysis study that looked at the
hepatocellular carcinoma recurrence rate and its risk factors after liver transplantation. The …

Hepatocellular carcinoma (HCC) is the most frequently diagnosed primary liver cancer with
a high mortality rate and imposes a huge burden on patients and society. Recently, ubiquitin …

Hepatocellular carcinoma (HCC) is a frequently seen malignant tumor globally. The
occurrence of cisplatin (DDP) resistance is one of the main reasons for the high mortality of …

Circular RNAs (circRNAs) have been reported to regulate the hepatocellular carcinoma
(HCC) chemoresistance and tumor progression by regulating gene expression. However …

Spontaneously ruptured hepatocellular carcinoma (SRHCC) is an uncommon and life-
threatening complication in patients with hepatocellular carcinoma (HCC). It is usually …

Aim To investigate predictors affecting survival in patients with spontaneously ruptured
hepatocellular carcinoma (srHCC). Methods One-hundred-and-twenty-seven patients …